Nilotinib
targeted anticancer therapy · kinase inhibitor
Nothing to addWhat this medicine is for
Nilotinib belongs to the category "targeted anticancer therapy (kinase inhibitor)". This targeted therapy attacks a specific mechanism of the tumour cells; it comes under a specialised hospital prescription.
For Nilotinib, in practice: Treats a cancer by targeting tumour cells. It is part of specialised, closely monitored care.
Under which brands it is found
In France, about 7 reimbursable presentations containing Nilotinib are recorded. It comes under various trade names and in generic form.
- Nilotinib Accord
- Nilotinib Biogaran
- Nilotinib Eg
- Nilotinib Teva
- Nilotinib Viatris
- Nilotinib Zentiva
- Tasigna
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
For Nilotinib, we offer no supplement. No nutritional supplementation is seriously justified as an addition to this treatment, and we would rather write that than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; outside of those, we do not sell for the sake of selling, and that is what gives weight to our five products.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Other areas » family and its neighbours.